501 – 510 of 3460
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
EpilepsyGAN : Synthetic Epileptic Brain Activities with Privacy Preservation
(
- Contribution to journal › Article
-
Mark
Biomarker testing in MCI patients—deciding who to test
(
- Contribution to journal › Article
-
Mark
Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
High prevalence of neurodevelopmental problems in adolescents eligible for bariatric surgery for severe obesity
(
- Contribution to journal › Article
-
Mark
The impact of demographic, clinical, genetic, and imaging variables on tau PET status
(
- Contribution to journal › Article
-
Mark
Burden of Neurological Disorders across the US from 1990-2017: A Global Burden of Disease Study
(
- Contribution to journal › Article
-
Mark
The Non-Motor Symptoms Scale in Parkinson’s disease : Validation and use
(
- Contribution to journal › Scientific review
-
Mark
Cross-disease analysis of depression, ataxia and dystonia highlights a role for synaptic plasticity and the cerebellum in the pathophysiology of these comorbid diseases
(
- Contribution to journal › Article
-
Mark
Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age
(
- Contribution to journal › Article
-
Mark
Association between Apolipoprotein e ϵ2 vs ϵ4, Age, and β-Amyloid in Adults without Cognitive Impairment
(
- Contribution to journal › Article